Finding new ways to treat pancreatic cancer using the body's natural rhythms
Discovery of Chronotherapeutic Candidate Targets in Pancreatic Cancer
This study is looking at how your body's natural daily rhythms can help make treatments for pancreatic cancer more effective, by finding the best times to give therapies based on how your tumor behaves.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11127029 on NIH RePORTER |
What this research studies
This research investigates how the body's internal clock, which regulates daily biological processes, can be harnessed to improve treatments for pancreatic cancer. By analyzing data from various biological databases, the team aims to identify specific patterns in tumor behavior that align with these natural rhythms. The goal is to develop targeted therapies that can be administered at optimal times to enhance their effectiveness against pancreatic cancer. This approach, known as chronotherapy, seeks to personalize treatment based on the unique characteristics of each patient's tumor.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with other types of cancer or those who are not diagnosed with pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promise in using chronotherapy for other cancers, suggesting potential for success in this novel application for pancreatic cancer.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Bishehsari, Faraz — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Bishehsari, Faraz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.